Annual ROA
15.75%
+2.03%+14.80%
31 December 2023
Summary:
Halozyme Therapeutics annual return on assets is currently 15.75%, with the most recent change of +2.03% (+14.80%) on 31 December 2023. During the last 3 years, it has fallen by -32.07% (-67.06%). HALO annual ROA is now -67.06% below its all-time high of 47.82%, reached on 31 December 2021.HALO ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
20.54%
+2.30%+12.61%
30 September 2024
Summary:
Halozyme Therapeutics quarterly return on assets is currently 20.54%, with the most recent change of +2.30% (+12.61%) on 30 September 2024. Over the past year, it has increased by +4.86% (+30.99%). HALO quarterly ROA is now -57.00% below its all-time high of 47.77%, reached on 30 September 2021.HALO Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +31.0% |
| 3 y3 years | -67.1% | -50.4% |
| 5 y5 years | +209.7% | +226.4% |
HALO ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -67.1% | +14.8% | -50.4% | +88.8% |
| 5 y | 5 years | -67.1% | +209.7% | -57.0% | +216.6% |
| alltime | all time | -67.1% | +101.8% | -57.0% | +101.1% |
Halozyme Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 20.54%(+12.6%) |
| June 2024 | - | 18.24%(+2.7%) |
| Mar 2024 | - | 17.76%(+13.3%) |
| Dec 2023 | 15.75%(+14.8%) | 15.68%(+12.5%) |
| Sept 2023 | - | 13.94%(+7.3%) |
| June 2023 | - | 12.99%(+19.4%) |
| Mar 2023 | - | 10.88%(-16.5%) |
| Dec 2022 | 13.72%(-71.3%) | 13.03%(-12.4%) |
| Sept 2022 | - | 14.88%(-49.1%) |
| June 2022 | - | 29.25%(-26.8%) |
| Mar 2022 | - | 39.94%(-3.5%) |
| Dec 2021 | 47.82%(+112.3%) | 41.41%(-13.3%) |
| Sept 2021 | - | 47.77%(+51.4%) |
| June 2021 | - | 31.56%(+19.6%) |
| Mar 2021 | - | 26.39%(+10.0%) |
| Dec 2020 | 22.53%(-256.9%) | 24.00%(+453.0%) |
| Sept 2020 | - | 4.34%(-151.9%) |
| June 2020 | - | -8.36%(-52.5%) |
| Mar 2020 | - | -17.61%(+8.4%) |
| Dec 2019 | -14.36%(-14.2%) | -16.25%(+70.9%) |
| Sept 2019 | - | -9.51%(-2.0%) |
| June 2019 | - | -9.70%(-13.2%) |
| Mar 2019 | - | -11.18%(-33.9%) |
| Dec 2018 | -16.73%(-203.8%) | -16.91%(-269.6%) |
| Sept 2018 | - | 9.97%(-42.7%) |
| June 2018 | - | 17.40%(-1.1%) |
| Mar 2018 | - | 17.59%(-4.5%) |
| Dec 2017 | 16.12%(-134.7%) | 18.41%(-161.4%) |
| Sept 2017 | - | -29.98%(-29.5%) |
| June 2017 | - | -42.50%(+0.7%) |
| Mar 2017 | - | -42.19%(+9.0%) |
| Dec 2016 | -46.48%(+150.7%) | -38.70%(+33.3%) |
| Sept 2016 | - | -29.03%(-2.7%) |
| June 2016 | - | -29.84%(+58.8%) |
| Mar 2016 | - | -18.79%(-2.1%) |
| Dec 2015 | -18.54%(-63.7%) | -19.19%(-24.5%) |
| Sept 2015 | - | -25.42%(+14.2%) |
| June 2015 | - | -22.25%(-32.0%) |
| Mar 2015 | - | -32.74%(-22.2%) |
| Dec 2014 | -51.07%(-27.7%) | -42.10%(-25.2%) |
| Sept 2014 | - | -56.25%(-6.5%) |
| June 2014 | - | -60.15%(-16.0%) |
| Mar 2014 | - | -71.57%(-2.1%) |
| Dec 2013 | -70.59% | -73.11%(+28.1%) |
| Sept 2013 | - | -57.09%(+0.9%) |
| June 2013 | - | -56.57%(+20.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | -46.85%(-1.2%) |
| Dec 2012 | -53.42%(+112.2%) | -47.40%(-28.7%) |
| Sept 2012 | - | -66.44%(+53.6%) |
| June 2012 | - | -43.26%(+53.9%) |
| Mar 2012 | - | -28.11%(+15.4%) |
| Dec 2011 | -25.17%(-60.2%) | -24.36%(+17.6%) |
| Sept 2011 | - | -20.72%(-52.1%) |
| June 2011 | - | -43.30%(-34.0%) |
| Mar 2011 | - | -65.61%(-5.0%) |
| Dec 2010 | -63.20%(-16.8%) | -69.05%(+7.2%) |
| Sept 2010 | - | -64.44%(-4.0%) |
| June 2010 | - | -67.14%(-4.6%) |
| Mar 2010 | - | -70.40%(-2.3%) |
| Dec 2009 | -75.93%(+40.5%) | -72.04%(-5.8%) |
| Sept 2009 | - | -76.50%(+5.7%) |
| June 2009 | - | -72.35%(+12.0%) |
| Mar 2009 | - | -64.58%(+19.0%) |
| Dec 2008 | -54.05%(+69.1%) | -54.28%(+29.0%) |
| Sept 2008 | - | -42.08%(+15.8%) |
| June 2008 | - | -36.33%(+16.8%) |
| Mar 2008 | - | -31.10%(+13.9%) |
| Dec 2007 | -31.96%(-27.9%) | -27.31%(-1.8%) |
| Sept 2007 | - | -27.80%(-11.1%) |
| June 2007 | - | -31.28%(-25.7%) |
| Mar 2007 | - | -42.11%(-31.4%) |
| Dec 2006 | -44.30%(-38.4%) | -61.35%(-28.0%) |
| Sept 2006 | - | -85.18%(-8.8%) |
| June 2006 | - | -93.35%(-1.4%) |
| Mar 2006 | - | -94.67%(-1.4%) |
| Dec 2005 | -71.93%(-32.5%) | -96.04%(-17.8%) |
| Sept 2005 | - | -116.83%(+1.5%) |
| June 2005 | - | -115.14%(+0.5%) |
| Mar 2005 | - | -114.57%(-12.3%) |
| Dec 2004 | -106.64%(-77.9%) | -130.71%(-36.7%) |
| Sept 2004 | - | -206.43%(+26.7%) |
| June 2004 | - | -162.88%(-10.3%) |
| Mar 2004 | - | -181.49%(-80.9%) |
| Dec 2003 | -481.88%(-45.5%) | -948.46%(-48.6%) |
| Sept 2003 | - | -1843.54%(+39.9%) |
| June 2003 | - | -1317.83%(+20.0%) |
| Mar 2003 | - | -1097.84%(+33.7%) |
| Dec 2002 | -884.09%(+481.2%) | -821.16%(+4469.6%) |
| Sept 2002 | - | -17.97%(+148.5%) |
| June 2002 | - | -7.23%(-129.2%) |
| Mar 2002 | - | 24.80% |
| Dec 2001 | -152.11% | - |
FAQ
- What is Halozyme Therapeutics annual return on assets?
- What is the all time high annual ROA for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly ROA year-on-year change?
What is Halozyme Therapeutics annual return on assets?
The current annual ROA of HALO is 15.75%
What is the all time high annual ROA for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual return on assets is 47.82%
What is Halozyme Therapeutics quarterly return on assets?
The current quarterly ROA of HALO is 20.54%
What is the all time high quarterly ROA for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly return on assets is 47.77%
What is Halozyme Therapeutics quarterly ROA year-on-year change?
Over the past year, HALO quarterly return on assets has changed by +4.86% (+30.99%)